AstraZeneca Resuming US Testing of COVID-19 Vaccine

AstraZeneca is resuming late-stage testing of its COVID-19 vaccine candidate in the U.S.  The British drugmaker said the Food and Drug Administration gave the company the go-ahead on Friday.